Key result
Lower maternal GDCA and TDCA levels correlate with worse insulin resistance in gestational diabetes.
Cross-Sectional (n=115)
Answers are grounded in this paper and cite their sources.
Cross-sectional study reveals reduced maternal glycodeoxycholic acid correlates with higher insulin resistance in gestational diabetes, suggesting its utility as a metabolic biomarker.
BackgroundGestational diabetes mellitus (GDM) is characterized by glycemia and insulin disorders. Bile acids (Bas) have emerged as vital signaling molecules in glucose metabolic regulation. Bas change in GDM are still unclear, it exerts great significance to illustrate the change of Bas in GDM.MethodsWe organized GDM patient (n = 67) and normal pregnant women (n = 48) around the oral glucose tolerance test (OGTT) screening period, fasting serums were collected for the measurement of Bas. Clinical data were collected and Bas metabolism profiles were analyzed in the GDM and normal glucose tolerance (NGT). Delivery characteristics, delivery gestational age and infant birthweight were abstracted from medical record to illustrate the differences among the groups.ResultsGDM patients exert the distinctive features compared with NGT, including higher BMI, glucose, insulin (both fasting and OGTT) and HbA1c levels. GDM also gained higher insulin resistance index (HOMA-IR) and decreased β-cell compensation (DIo). Total bile acids (TBA) remained stable, but glycodeoxycholic acid (GDCA) and taurodeoxycholic acid (TDCA) declined significantly in GDM. GDCA was inversely correlated with HOMA-IR and positively correlated with DIo. There exists no obvious difference in clinical outcome between GDM and NGT. However, GDM patients with high HOMA-IR and low DIo are inclined to suffering higher cesarean delivery rate and earlier delivery gestational age. ConclusionsGDM with significantly increased insulin resistance and declined DIo elevated the worse clinical outcome, GDCA could be a valuable biomarker to evaluate insulin resistance and DIo in GDM.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2020) conducted a cross-sectional in Gestational diabetes mellitus (GDM) (n=115). Gestational diabetes mellitus (GDM) and maternal bile acid profiles (GDCA, TDCA) vs. Normal glucose tolerance (NGT) pregnant women was evaluated on Fasting serum bile acid metabolism profiles (specifically GDCA and TDCA), insulin resistance (HOMA-IR), and β-cell compensation (DIo). Maternal glycodeoxycholic acid (GDCA) and taurodeoxycholic acid (TDCA) declined significantly in GDM (n=67 vs n=48 controls), with GDCA inversely correlated with HOMA-IR and positively with DIo.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: